Shanghai Cell Therapy Group
Shanghai Cell Therapy Group is a biotech company.
Launch date
Employees
Market cap
-
Enterprise valuation
$543—814m (Dealroom.co estimates Dec 2018.)
Shanghai Shanghai (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
CNY185m | Series B | ||
$40.0m | Series C | ||
* | $136m | Series C | |
| Total Funding | $201m | ||
Related Content
Recent News about Shanghai Cell Therapy Group
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.